JPMorgan Chase & Co’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.8M Buy
1,332,366
+240,676
+22% +$1.95M ﹤0.01% 2160
2025
Q1
$9.15M Sell
1,091,690
-123,282
-10% -$1.03M ﹤0.01% 2249
2024
Q4
$9.62M Sell
1,214,972
-82,122
-6% -$650K ﹤0.01% 2263
2024
Q3
$10.8M Buy
1,297,094
+777,568
+150% +$6.47M ﹤0.01% 2109
2024
Q2
$3.3M Buy
519,526
+97,403
+23% +$619K ﹤0.01% 2785
2024
Q1
$2.56M Buy
422,123
+236,082
+127% +$1.43M ﹤0.01% 2994
2023
Q4
$1.13M Sell
186,041
-400,718
-68% -$2.43M ﹤0.01% 3458
2023
Q3
$2.48M Buy
586,759
+54,229
+10% +$229K ﹤0.01% 2882
2023
Q2
$1.65M Buy
532,530
+217,193
+69% +$673K ﹤0.01% 3145
2023
Q1
$439K Buy
315,337
+8,295
+3% +$11.5K ﹤0.01% 3901
2022
Q4
$611K Sell
307,042
-61,919
-17% -$123K ﹤0.01% 3652
2022
Q3
$745K Sell
368,961
-5,440
-1% -$11K ﹤0.01% 3543
2022
Q2
$1.19M Buy
374,401
+11,016
+3% +$35K ﹤0.01% 3350
2022
Q1
$1.52M Buy
363,385
+859
+0.2% +$3.58K ﹤0.01% 3357
2021
Q4
$1.74M Sell
362,526
-12,148
-3% -$58.2K ﹤0.01% 3311
2021
Q3
$2M Sell
374,674
-28,161
-7% -$150K ﹤0.01% 3184
2021
Q2
$2.06M Sell
402,835
-21,267
-5% -$109K ﹤0.01% 3200
2021
Q1
$2.85M Sell
424,102
-63,570
-13% -$428K ﹤0.01% 3011
2020
Q4
$2.23M Buy
487,672
+450,699
+1,219% +$2.06M ﹤0.01% 2898
2020
Q3
$142K Buy
36,973
+3,391
+10% +$13K ﹤0.01% 3901
2020
Q2
$160K Sell
33,582
-5,397
-14% -$25.7K ﹤0.01% 3765
2020
Q1
$136K Sell
38,979
-3,359
-8% -$11.7K ﹤0.01% 3848
2019
Q4
$204K Sell
42,338
-291,551
-87% -$1.4M ﹤0.01% 3806
2019
Q3
$968K Buy
333,889
+283,853
+567% +$823K ﹤0.01% 3088
2019
Q2
$355K Buy
50,036
+26,285
+111% +$186K ﹤0.01% 3516
2019
Q1
$336K Sell
23,751
-854
-3% -$12.1K ﹤0.01% 3545
2018
Q4
$333K Buy
24,605
+450
+2% +$6.09K ﹤0.01% 3573
2018
Q3
$536K Buy
24,155
+2,739
+13% +$60.8K ﹤0.01% 3461
2018
Q2
$352K Buy
+21,416
New +$352K ﹤0.01% 3592